Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3454 | 1517 | 36.7 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
258 | 3 | STROKE//INTRACEREBRAL HEMORRHAGE//CEREBRAL ISCHEMIA | 44849 |
3454 | 2 | EDARAVONE//CHRONIC CEREBRAL HYPOPERFUSION//HYDROGEN RICH SALINE | 1517 |
21218 | 1 | HYDROGEN RICH SALINE//ING MED//ELECTROLYZED REDUCED WATER | 428 |
21669 | 1 | EDARAVONE//MCI 186//FREE RADICAL SCAVENGER | 410 |
22264 | 1 | CHRONIC CEREBRAL HYPOPERFUSION//2 3 5 TRIPHENYLTERAZOLIUM CHLORIDE STAINING//CNS CVS PHARMACOL | 388 |
31425 | 1 | CLAUSENAMIDE//ALKENYL NONAFLATES//CLAUSENAMIDE ENANTIOMERS | 153 |
32512 | 1 | DL 3 N BUTYLPHTHALIDE//L 3 N BUTYLPHTHALIDE//3 N BUTYLPHTHALIDE | 138 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EDARAVONE | authKW | 2060509 | 12% | 58% | 177 |
2 | CHRONIC CEREBRAL HYPOPERFUSION | authKW | 928138 | 6% | 55% | 84 |
3 | HYDROGEN RICH SALINE | authKW | 460511 | 2% | 74% | 31 |
4 | ING MED | address | 395283 | 4% | 36% | 55 |
5 | DL 3 N BUTYLPHTHALIDE | authKW | 369830 | 1% | 88% | 21 |
6 | MCI 186 | authKW | 328733 | 1% | 78% | 21 |
7 | CLAUSENAMIDE | authKW | 259690 | 1% | 65% | 20 |
8 | ELECTROLYZED REDUCED WATER | authKW | 232049 | 1% | 82% | 14 |
9 | L 3 N BUTYLPHTHALIDE | authKW | 193215 | 1% | 80% | 12 |
10 | ALKENYL NONAFLATES | authKW | 182972 | 1% | 91% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 3121 | 28% | 0% | 421 |
2 | Pharmacology & Pharmacy | 899 | 16% | 0% | 248 |
3 | Clinical Neurology | 556 | 10% | 0% | 148 |
4 | Medicine, Research & Experimental | 508 | 8% | 0% | 120 |
5 | Peripheral Vascular Diseases | 506 | 6% | 0% | 92 |
6 | Chemistry, Medicinal | 191 | 4% | 0% | 62 |
7 | Chemistry, Organic | 171 | 6% | 0% | 98 |
8 | Integrative & Complementary Medicine | 159 | 1% | 0% | 21 |
9 | Transplantation | 80 | 2% | 0% | 29 |
10 | Cell Biology | 71 | 6% | 0% | 86 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ING MED | 395283 | 4% | 36% | 55 |
2 | NAVAL MED | 155307 | 4% | 12% | 63 |
3 | MOL HYDROGEN MED | 80504 | 0% | 67% | 6 |
4 | DEV AGING SCI | 71909 | 1% | 19% | 19 |
5 | CNS CVS PHARMACOL | 71880 | 0% | 71% | 5 |
6 | CONSCI | 64405 | 0% | 80% | 4 |
7 | TIANJIN ANESTHESIOL | 62692 | 1% | 35% | 9 |
8 | ADV MED CLIN CANC | 40254 | 0% | 100% | 2 |
9 | BIOSTAT SECTSHOWA KU | 40254 | 0% | 100% | 2 |
10 | DEVAOBA KU | 40254 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT NEUROVASCULAR RESEARCH | 8191 | 1% | 3% | 14 |
2 | NEURAL REGENERATION RESEARCH | 2515 | 1% | 1% | 19 |
3 | REDOX REPORT | 2131 | 1% | 1% | 10 |
4 | NEUROLOGICAL RESEARCH | 1734 | 1% | 1% | 17 |
5 | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | 1694 | 1% | 1% | 12 |
6 | BRAIN RESEARCH | 1493 | 4% | 0% | 61 |
7 | JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 1477 | 1% | 0% | 20 |
8 | STROKE | 1219 | 2% | 0% | 30 |
9 | TRANSLATIONAL STROKE RESEARCH | 1129 | 0% | 1% | 5 |
10 | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES | 1024 | 1% | 0% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EDARAVONE | 2060509 | 12% | 58% | 177 | Search EDARAVONE | Search EDARAVONE |
2 | CHRONIC CEREBRAL HYPOPERFUSION | 928138 | 6% | 55% | 84 | Search CHRONIC+CEREBRAL+HYPOPERFUSION | Search CHRONIC+CEREBRAL+HYPOPERFUSION |
3 | HYDROGEN RICH SALINE | 460511 | 2% | 74% | 31 | Search HYDROGEN+RICH+SALINE | Search HYDROGEN+RICH+SALINE |
4 | DL 3 N BUTYLPHTHALIDE | 369830 | 1% | 88% | 21 | Search DL+3+N+BUTYLPHTHALIDE | Search DL+3+N+BUTYLPHTHALIDE |
5 | MCI 186 | 328733 | 1% | 78% | 21 | Search MCI+186 | Search MCI+186 |
6 | CLAUSENAMIDE | 259690 | 1% | 65% | 20 | Search CLAUSENAMIDE | Search CLAUSENAMIDE |
7 | ELECTROLYZED REDUCED WATER | 232049 | 1% | 82% | 14 | Search ELECTROLYZED+REDUCED+WATER | Search ELECTROLYZED+REDUCED+WATER |
8 | L 3 N BUTYLPHTHALIDE | 193215 | 1% | 80% | 12 | Search L+3+N+BUTYLPHTHALIDE | Search L+3+N+BUTYLPHTHALIDE |
9 | ALKENYL NONAFLATES | 182972 | 1% | 91% | 10 | Search ALKENYL+NONAFLATES | Search ALKENYL+NONAFLATES |
10 | MOLECULAR HYDROGEN | 138110 | 2% | 22% | 31 | Search MOLECULAR+HYDROGEN | Search MOLECULAR+HYDROGEN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OHNO, K , ITO, M , ICHIHARA, M , ITO, M , (2012) MOLECULAR HYDROGEN AS AN EMERGING THERAPEUTIC MEDICAL GAS FOR NEURODEGENERATIVE AND OTHER DISEASES.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. VOL. . ISSUE . P. - | 80 | 86% | 34 |
2 | ZHENG, XF , SUN, XJ , XIA, ZF , (2011) HYDROGEN RESUSCITATION, A NEW CYTOPROTECTIVE APPROACH.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 38. ISSUE 3. P. 155 -163 | 65 | 79% | 30 |
3 | OHTA, S , (2014) MOLECULAR HYDROGEN AS A PREVENTIVE AND THERAPEUTIC MEDICAL GAS: INITIATION, DEVELOPMENT AND POTENTIAL OF HYDROGEN MEDICINE.PHARMACOLOGY & THERAPEUTICS. VOL. 144. ISSUE 1. P. 1 -11 | 65 | 51% | 27 |
4 | KIKUCHI, K , TAKESHIGE, N , MIURA, N , MORIMOTO, Y , ITO, T , TANCHAROEN, S , MIYATA, K , KIKUCHI, C , IIDA, N , UCHIKADO, H , ET AL (2012) BEYOND FREE RADICAL SCAVENGING: BENEFICIAL EFFECTS OF EDARAVONE (RADICUT) IN VARIOUS DISEASES (REVIEW).EXPERIMENTAL AND THERAPEUTIC MEDICINE. VOL. 3. ISSUE 1. P. 3-8 | 51 | 74% | 24 |
5 | KIKUCHI, K , UCHIKADO, H , MIYAGI, N , MORIMOTO, Y , ITO, T , TANCHAROEN, S , MIURA, N , MIYATA, K , SAKAMOTO, R , KIKUCHI, C , ET AL (2011) BEYOND NEUROLOGICAL DISEASE: NEW TARGETS FOR EDARAVONE (REVIEW).INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. VOL. 28. ISSUE 6. P. 899-906 | 58 | 62% | 15 |
6 | CHUAI, YH , QIAN, LR , SUN, XJ , CAI, JM , (2012) MOLECULAR HYDROGEN AND RADIATION PROTECTION.FREE RADICAL RESEARCH. VOL. 46. ISSUE 9. P. 1061 -1067 | 51 | 64% | 8 |
7 | IIDA, A , NOSAKA, N , YUMOTO, T , KNAUP, E , NAITO, H , NISHIYAMA, C , YAMAKAWA, Y , TSUKAHARA, K , TERADO, M , SATO, K , ET AL (2016) THE CLINICAL APPLICATION OF HYDROGEN AS A MEDICAL TREATMENT.ACTA MEDICA OKAYAMA. VOL. 70. ISSUE 5. P. 331 -337 | 33 | 89% | 0 |
8 | HONG, Y , CHEN, S , ZHANG, JM , (2010) HYDROGEN AS A SELECTIVE ANTIOXIDANT: A REVIEW OF CLINICAL AND EXPERIMENTAL STUDIES.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 38. ISSUE 6. P. 1893 -1903 | 34 | 79% | 44 |
9 | WATANABE, T , TAHARA, M , TODO, S , (2008) THE NOVEL ANTIOXIDANT EDARAVONE: FROM BENCH TO BEDSIDE.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 2. P. 101-114 | 51 | 50% | 85 |
10 | OSTOJIC, SM , (2015) MOLECULAR HYDROGEN IN SPORTS MEDICINE: NEW THERAPEUTIC PERSPECTIVES.INTERNATIONAL JOURNAL OF SPORTS MEDICINE. VOL. 36. ISSUE 4. P. 273 -279 | 31 | 74% | 5 |
Classes with closest relation at Level 2 |